Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Ketorolac price, strengths & recalls

Generic of Acular, Acuvail

Pharmacies pay $5.11 for 30 tablets of Ketorolac 10 mg tablet this week, and from $5.11 to $63.09 across its 5 priced strengths and forms. 57 manufacturers make it. It is in shortage (unavailable). 12 recalls are ongoing. Its official label last changed on October 26, 2026.

Unavailable12 open recallsGeneric
Pharmacies pay$5.11for 30 tablets of 10 mg tablet+3.5% in 4 weeks
Fair cash price
$16.38
Strengths
5
Makers
57
Updated
Nov 11

Ketorolac price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
4 mg/mL eye drops$12.62$63.09 / 5 mL-0.5%+3.4%
5 mg/mL eye drops$1.16$5.82 / 5 mL-13.0%-23.7%
15 mg/mL, 1 mL injectionNot priced this week
30 mg/mL, 1 mL injection$1.00$25.11 / 25 mL-1.3%+8.3%
30 mg/mL, 2 mL injection$0.6167$30.83 / 50 mL+11.6%+13.4%
10 mg tablet$0.1703$5.11 / 30 tablets+3.5%-22.7%

The lowest cost per tablet is 10 mg tablet at $0.1703. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Brand names of ketorolac

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

In shortage26 products are short or being discontinued
12 ongoing recalls54 recalls on record, latest Jan 14, 2026

Shortages

  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2027
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Sagent Pharmaceuticals · Limited Availability · Reason: Delay in shipping of the drug · Updated Nov 6, 2026Estimated recovery: Mid-November 2026, Product in transit and expected to arrive week of Nov 12th
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Sagent Pharmaceuticals · Available · Updated Nov 6, 2026
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Sagent Pharmaceuticals · Unavailable · Reason: Demand increase for the drug · Updated Nov 6, 2026Product in transit with expected delivery in December 2026
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Estimated recovery: TBD
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Next release not available at this time. Check wholesalers for inventory.
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Next release not available at this time. Check wholesalers for inventory.
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)Baxter Healthcare · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Estimated recovery: December 2026
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Estimated recovery: TBD

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 54 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for ketorolac? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedOctober 26, 2026
Version6 of 6
EffectiveOct 22, 2026
Read the label

Ketorolac Tromethamine Tablets USP, 10mg Rx only

This drug has a boxed warning

WARNING

Ketorolac tromethamine tablets, a nonsteroidal anti-inflammatory drug (NSAID), are indicated for the short-term (up to 5 days in adults), management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment following IV or IM dosing of ketorolac tromethamine, if necessary. The total combined duration of use of ketorolac tromethamine tablets and ketorolac tromethamine should not exceed 5 days.

Ketorolac tromethamine tablets are not indicated for use in pediatric patients and they are NOT indicated for minor or chronic painful conditions. Increasing the dose of ketorolac tromethamine tablets beyond a daily maximum of 40 mg in adults will not provide better efficacy but will increase the risk of developing serious adverse events.

GASTROINTESTINAL RISK

Ketorolac tromethamine, including ketorolac tromethamine tablets can cause peptic ulcers, gastrointestinal bleeding and/or perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Therefore, ketorolac tromethamine is CONTRAINDICATED in patients with active peptic ulcer disease, in patients with recent gastrointestinal bleeding or perforation, and in patients with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly patients are at greater risk for serious gastrointestinal events (see

WARNINGS).

CARDIOVASCULAR THROMBOTIC EVENTS

Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use (see

WARNINGSand

PRECAUTIONS).

Ketorolac tromethamine tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery (see

CONTRAINDICATIONSand

WARNINGS).

RENAL RISK

Ketorolac tromethamine is CONTRAINDICATED in patients with advanced renal impairment and in patients at risk for renal failure due to volume depletion (see

WARNINGS).

RISK OF BLEEDING

Ketorolac tromethamine inhibits platelet function and is, therefore, CONTRAINDICATED in patients with suspected or confirmed cerebrovascular bleeding, patients with hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding (see

WARNINGSand

PRECAUTIONS).

Ketorolac tromethamine is CONTRAINDICATED as prophylactic analgesic before any major surgery.

RISK DURING LABOR AND DELIVERY

The use of ketorolac tromethamine in labor and delivery is contraindicated because it may adversely affect fetal circulation and inhibit uterine contractions.

CONCOMITANT USE WITH NSAIDs

Ketorolac tromethamine is CONTRAINDICATED in patients currently receiving aspirin or NSAIDs because of the cumulative risk of inducing serious NSAID-related side effects.

SPECIAL POPULATIONS

Dosage should be adjusted for patients 65 years or older, for patients under 50 kg (110 lbs) of body weight (see

DOSAGE AND ADMINISTRATION) and for patients with moderately elevated serum creatinine (see

WARNINGS).

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA021528 · Abbvie
First approved
May 30, 2003 (23 years ago)
Latest approved change
March 5, 2021
Approved label
PDF, Mar 9, 2021
Generic makers
26 approved generic applications on the market
Last patent listed
November 24, 2027

Ketorolac questions

How much does ketorolac cost without insurance?

Pharmacies pay about $5.11 for 30 tablets of ketorolac 10 mg tablet ($0.1703 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $16.38. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of ketorolac?

Ketorolac is sold as Acular, Acuvail. The generic has the same active ingredient and usually costs far less.

Is ketorolac in shortage?

Yes. 26 products are listed as in shortage or being discontinued (unavailable). See which ones.

Has ketorolac been recalled?

54 recalls on record, 12 ongoing. Recalls name specific lots - check yours.

When did the ketorolac label last change?

The official label was last updated on October 26, 2026 (version 6). See what changed.

Talk about ketorolac

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.